SCHEMBL1663749

SCHEMBL1663749

[CH2]C(N)(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464728 0.72
SCHEMBL4018045 0.69
SCHEMBL178124 0.67
SCHEMBL1164835 0.67
Tromethamine SCHEMBL10455580 0.67 MEN1 (0.83)
Tromethamine SCHEMBL11155260 0.64 MEN1 (0.77)
Tromethamine SCHEMBL4950340 0.64 MEN1 (0.77)
Tromethamine SCHEMBL3696191 0.64
SCHEMBL1032719 0.64
SCHEMBL1985220 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110698459-A 1-phenyl-2-pyridylalkyl alcohol derivatives as phosphodiesterase inhibitors 奇斯药制品公司 2020-01-17 CN disclosed
EP-2306994-B1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC (US) 2013-08-14 EP disclosed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
US-7842685-B2 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-11-30 US disclosed
US-20100029611-A1 S1P1 receptor agonists and use thereof AMGEN INC. (US) 2010-02-04 US disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed
US-4438260-A Sisomicin compounds BAYER AKTIENGESELLSCHAFT (DE) 1984-03-20 US disclosed
EP-0056575-A1 Sisomicin derivatives, process for their preparation and their use as pharmaceutical compositions BAYER AG (DE) 1982-07-28 EP disclosed